Top Markets
#1 EXOD EXOD +56.80%
#2 Cysic Cysic +14.17%
#3 Biconomy Biconomy +9.35%
#4 Fabric Protocol Fabric Protocol +7.20%
#5 Fake World Assets Fake World Assets +5.60%
#6 Collect on Fanable Collect on Fanable +4.30%
#7 Cap Cap +3.90%
#8 Dual Dual +3.58%
#9 Figure Heloc Figure Heloc +3.49%
#10 Avantis Avantis +3.32%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Roquefort Therapeutics plc Roquefort Therapeutics plc

Roquefort Therapeutics plc

ROQ
Kedudukan dalam Saham #37956
Roquefort Therapeutics plc functions as a biotechnology firm, focusing its... Roquefort Therapeutics plc functions as a biotechnology firm, focusing its efforts on the discovery and development of innovative pharmaceutical treatments. The company's primary research objective is to develop therapies that target Midkine, a circulating growth factor protein and pro-inflammatory mediator, for applications in cancer treatment. Established in 2020, Roquefort Therapeutics plc has its main operations based in London, United Kingdom.
Harga Saham
$0.10205262
Disegerakkan terakhir: 2026-04-23
Modal Pasaran
$1.32M
Perubahan (1 hari)
5.19%
Perubahan (1 tahun)
-54.38%
Negara
GB
Perdagangan Roquefort Therapeutics plc (ROQ)

Kategori

Healthcare
Nisbah P/B bagi Roquefort Therapeutics plc (ROQ)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Roquefort Therapeutics plc, nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Roquefort Therapeutics plc dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE